The Scope of Things

Episode: 54 - Ken Getz and Rick Ward on Why Source Preparation Delays Clinical Trials

There is a startup delay that often goes undetected: source preparation. Ken Getz, executive director at the Tufts Center for the Study of Drug Development, and Rick Ward

Episode: 53 - Daphne Smyth on the Chinese Drug Development Market Expansion

With increasing efforts to scale into international markets, what can we expect from China's drug development industry? Joining the podcast is Daphne Smyth, head of

Episode: 52 - Raj Indupuri on Adoption Hurdles with AI Agents

Clinical trial support companies are rapidly adopting AI, but sponsors have been more hesitant. Raj Indupuri, CEO of eClinical Solutions, gives the top three reasons behi

Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.

Are medical advancements closing or widening medical disparities? Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation, breaks down w

Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works

Health equity is being reorganized, renamed, or quietly deprioritized. Ramona Burress, co-founder of Onyx Health Collective, and Cassandra O’Neal, founder of Illuminated

Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030

What will AI and clinical trials look like in the year 2030? Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Thi

Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials

How can electronic capture of clinical outcome assessments (eCOA) help with the unique challenges of pediatric rare disease trials? Florence Mowlem, chief scientific offi

Episode: 47 - Joseph Kim on Pragmatic Solutions to Age-Old Problems

Joining this month’s episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company’s first-ever CORE Symposium, where ph

Episode: 46 - Dan Drozd on How Noninterventional Studies Can Change the Clinical Research Game

Noninterventional studies in clinical research are underutilized in clinical research and inefficient. Dan Drozd, CMO of PicnicHealth, knows we can do better. With host D

Episode: 45 - Doug Bain on Streamlining Clinical Trials

Doug Bain, founder and consulting partner of ClinFlo, discusses his proposed regulatory blueprint for digital trials in the latest episode of The Scope of Things podcast.

Episode 44 - SCOPE Europe 2025 on AI Literacy Training, Reducing Excess Data Collection, Combating Superbugs

This episode of the Scope of Things features an exclusive panel at SCOPE Europe 2025 covering regulatory requirements for AI literacy training, featuring industry executi

Episode: 43 - Overcoming the Deadlock in Patient Recruitment With Christine Senn

For decades, clinical trial recruitment has been the biggest challenge in the industry. Christine Senn, senior vice president of Site-Sponsor Innovation at Advarra, offer

Episode: 42 - Myeloma Research on a Global Scale with Joseph Mikhael

Joseph Mikhael, chief medical officer of The International Myeloma Foundation, and his organization are pulling all the stops to find a true cure for multiple myeloma, a

Episode: 41 - How Non-Profits Are Filling Unique Roles in Clinical Research

Children’s Tumor Foundation CEO Annette Bakker discusses what non-profit organizations uniquely bring to clinical research and new financial models sustaining their contr

Episode 40: The Advancement and Implementation of Pragmatic Trials

The latest on a trio of pragmatic trials for lung cancer treatment, the implementation of national-scale pharmacogenomic testing, an efficient approach to comparing commo

Episode: 39 - Blythe Adamson on Patient-Level Real-World Data for Multinational Oncology Research

In this episode of the Scope of Things, host Deborah Borfitz brings you the latest news on AI-recommended precision dosing, organoid drug testing aiding treatment selecti

Episode: 38 - Tackling the Misinformation Epidemic with Briony

In this episode of the Scope of Things, host Deborah Borfitz brings you the news on a precision medicine initiative in Sweden integrating research with healthcare, newly

Episode: 37 - Using AI to Translate Clinical Trial Results with Ravi Parikh

In this episode of The Scope of Things, host Deborah Borfitz covers the latest news, including setting expectations for Phase II cancer trials, key learnings about dement

Episode: 36 - Wes Michael on Enhancing Patient Voices and Sharing Their Insights

In this episode of the Scope of Things, host Deborah Borfitz delivers the latest on an AI-powered trial screening tool that outperforms research staff, a strategy report

Episode: 35 - SCOPE 2025, Participant Engagement Award Winners, How AI is Helping Trials, and More

In this episode of the Scope of Things, host Deborah Borfitz provides the latest on new criteria for defining and diagnosing obesity, the case for including pregnant wome